Hepatitis C virus serotype II responds more favorably to interferon-α therapy
- 1 January 1994
- journal article
- clinical trial
- Published by Elsevier in Journal of Hepatology
- Vol. 21 (1), 130-132
- https://doi.org/10.1016/s0168-8278(94)80149-5
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Significance of antibody to the host cellular gene derived epitope GOR in chronic hepatitis C virus infectionJournal of Hepatology, 1993
- Significance of serum hepatitis C virus RNA levels in chronic hepatitis CThe Lancet, 1993
- Antigenicities of Group I and II Hepatitis C Virus Polypeptides—Molecular Basis of DiagnosisVirology, 1993
- Detection of Hepatitis C Virus by Polymerase Chain Reaction and Response to Interferon–α Therapy: Relationship to Genotypes of Hepatitis C VirusHepatology, 1992
- HCV genotypes in chronic hepatitis C and response to interferonThe Lancet, 1992
- Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sourcesJournal of General Virology, 1992
- Recombinant Interferon Alfa Therapy for Chronic Hepatitis CNew England Journal of Medicine, 1989
- Treatment of Chronic Hepatitis C with Recombinant Interferon AlfaNew England Journal of Medicine, 1989